Forman Stephen J. 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Apr 26, 2021
Insider Transaction Report
Form 4
Forman Stephen J.
Director
Transactions
- Exercise/Conversion
Common Stock
2021-04-22$0.96/sh+33,334$32,001→ 58,137 total
Holdings
- 16,667(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Reported Person exercised options to acquire an aggregate of 33,334 shares.